back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2019-01-14 Tx date 2019-01-11 |
$ARZ
Aralez Pharmaceuticals Inc. |
Armstrong, Jennifer Lou
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
58 - Expiration of rights
|
-52,632 vol |
169,275 | |
| Filed 2018-06-25 Tx date 2018-06-22 |
$ARZ
Aralez Pharmaceuticals Inc. |
Armstrong, Jennifer Lou
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-8,482.50
-21,750 vol $0.39 each |
62,343 | |
| Filed 2018-06-25 Tx date 2018-06-22 |
$ARZ
Aralez Pharmaceuticals Inc. |
Armstrong, Jennifer Lou
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$8,482
+21,750 vol $0.39 each |
94,482 | |
| Filed 2018-05-16 Tx date 2018-05-11 |
$ARZ
Aralez Pharmaceuticals Inc. |
Armstrong, Jennifer Lou
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-7,556.0837
-15,031 vol $0.50 each |
84,093 | |
| Filed 2018-05-16 Tx date 2018-05-11 |
$ARZ
Aralez Pharmaceuticals Inc. |
Armstrong, Jennifer Lou
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$7,556
+15,031 vol $0.50 each |
72,732 | |
| Filed 2018-03-21 Tx date 2018-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Armstrong, Jennifer Lou
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-19,262.58
-10,526 vol $1.83 each |
99,124 | |
| Filed 2018-03-21 Tx date 2018-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Armstrong, Jennifer Lou
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$19,262
+10,526 vol $1.83 each |
57,701 | |
| Filed 2018-03-20 Tx date 2018-03-15 |
$ARZ
Aralez Pharmaceuticals Inc. |
Armstrong, Jennifer Lou
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+98,600 vol |
221,907 | |
| Filed 2017-06-23 Tx date 2017-06-22 |
$ARZ
Aralez Pharmaceuticals Inc. |
Armstrong, Jennifer Lou
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$28,927
+21,750 vol $1.33 each |
47,175 | |
| Filed 2017-06-23 Tx date 2017-06-22 |
$ARZ
Aralez Pharmaceuticals Inc. |
Armstrong, Jennifer Lou
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-28,927.50
-21,750 vol $1.33 each |
109,650 | |
| Filed 2017-05-12 Tx date 2017-05-11 |
$ARZ
Aralez Pharmaceuticals Inc. |
Armstrong, Jennifer Lou
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+45,096 vol |
131,400 | |
| Filed 2017-05-12 Tx date 2017-05-11 |
$ARZ
Aralez Pharmaceuticals Inc. |
Armstrong, Jennifer Lou
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+52,104 vol |
78,834 | |
| Filed 2017-03-24 Tx date 2017-03-15 |
$ARZ
Aralez Pharmaceuticals Inc. |
Armstrong, Jennifer Lou
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+70,675 vol |
123,307 | |
| Filed 2017-03-22 Tx date 2017-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Armstrong, Jennifer Lou
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$23,683
+10,526 vol $2.25 each |
25,425 | |
| Filed 2017-03-22 Tx date 2017-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Armstrong, Jennifer Lou
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-23,683.50
-10,526 vol $2.25 each |
86,304 | |
| Filed 2016-06-24 Tx date 2016-06-22 |
$ARZ
Aralez Pharmaceuticals Inc. |
Armstrong, Jennifer Lou
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-72,641.66
-21,749 vol $3.34 each |
96,830 | |
| Filed 2016-06-24 Tx date 2016-06-22 |
$ARZ
Aralez Pharmaceuticals Inc. |
Armstrong, Jennifer Lou
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$49,762
+14,899 vol $3.34 each |
14,899 | |
| Filed 2016-03-22 Tx date 2016-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Armstrong, Jennifer Lou
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+26,730 vol |
26,730 | |
| Filed 2016-03-22 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Armstrong, Jennifer Lou
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-03-22 Tx date 2016-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Armstrong, Jennifer Lou
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+52,632 vol |
52,632 | |
| Filed 2016-03-22 Tx date 2016-03-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Armstrong, Jennifer Lou
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+31,579 vol |
118,579 | |
| Filed 2016-03-22 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Armstrong, Jennifer Lou
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-02-18 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Armstrong, Jennifer Lou
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-02-18 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Armstrong, Jennifer Lou
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
21,853 | ||
| Filed 2016-02-18 Tx date 2016-02-17 |
$ARZ
Aralez Pharmaceuticals Inc. |
Armstrong, Jennifer Lou
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+65,147 vol |
87,000 | |
| Filed 2016-02-18 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Armstrong, Jennifer Lou
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-02-12 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Armstrong, Jennifer Lou
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
21,853 |